02235.HK香港交易所 · 主板 MainBPre-revenue biotech (Listing Rules ch.18A)
Microtech Medical 微泰醫療
Other Healthcare 其他医疗保健
HK$6.83−HK$0.08 · −1.16%
Open 开盘
HK$7.00
High 最高
HK$7.00
Low 最低
HK$6.83
Prev Close 昨收
HK$6.91
Volume 成交量
1.9万股
Turnover 成交额
HK$13.4万
Mkt Cap 总市值
HK$28亿
P/E 市盈率
63.8×
Recent Activity 近期动态All Filings 全部公告 →
No significant filings since 29 May 2026.
自 29 May 2026 起无重大公告。
6.507.007.508.00
Volume 成交量
250.9万
Sep 25Dec 25Mar 26Jun 26Sep 26
Substantial Shareholders 主要股东
Interests of 5% or more disclosed to HKEX under Part XV of the SFO · 10 largest of 25 · Stake as % of issued voting shares of the class 该类别已发行有投票权股份
Several holders often report the same shares, so the stakes do not add up.
22.88%
OrbiMed Asia Partners V, L.P.
Institution 机构
2,426.0万股 · As of 截至 26 Nov 2025
14.34%
OrbiMed Asia GP V, L.P.
Institution 机构
2,426.0万股 · As of 截至 26 Nov 2025
14.34%
OrbiMed Advisors V Limited
Institution 机构
2,426.0万股 · As of 截至 26 Nov 2025
14.34%
UBS Fund Management (Luxembourg) S.A.
Institution 机构
630.6万股 · As of 截至 19 Oct 2021
9.93%
7.32%
LAV Asset Management (Hong Kong) Limited
Institution 机构
1,246.5万股 · As of 截至 18 Nov 2022
7.32%
QM32 Limited
Institution 机构
1,166.3万股 · As of 截至 17 Jun 2026
6.89%
Qiming Venture Partners V, L.P.
Institution 机构
1,166.3万股 · As of 截至 17 Jun 2026
6.89%
6.89%